Insulin-like growth factor-I and cancer risk
- 31 August 2004
- journal article
- review article
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 14 (4) , 261-269
- https://doi.org/10.1016/j.ghir.2004.01.005
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Growth hormone therapy and Quality of Life: possibilities, pitfalls and mechanismsJournal of Endocrinology, 2003
- Potential therapeutic strategies to interrupt insulin-like growth factor signaling in breast cancerSeminars in Oncology, 2003
- IGF‐I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3‐E1 osteoblastic cellsJournal of Cellular Biochemistry, 2003
- Breast cancer and hormone-replacement therapy: the Million Women StudyPublished by Elsevier ,2003
- Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude miceJournal of Neurosurgery, 2001
- Serum insulin-like growth factor-I and breast cancerInternational Journal of Cancer, 2000
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Brain tumor recurrence in children treated with growth hormone: The National Cooperative Growth Study experienceThe Journal of Pediatrics, 1996
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896